Empagliflozin in Patients With Cirrhosis and Ascites
Abroad (travel likely)RecruitingPHASE2
Conditions
Cirrhosis · Liver Failure
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yale University, New Haven, Connecticut, United States
Contact: Study coordinator (Katherine Keith)
Study leads
Jeffrey Testani, MD
Principal Investigator
Yale University